// App-Quantinova.ai

3016 : Medical image computing to assess tumor infiltrating CD8 T cells, tumor immune phenotype and response to anti-PD-1/PD-L1 immunotherapy in prospective phase 1 trials.

Researchers

Presenter

  • Roger Sun

Principal Investigators

  • Maria Vakalopoulou

  • Laurent Dercle

  • Stephane Champiat

  • Shan Rong Han

  • Loic Verlingue

  • David Brandao

  • Samy Ammari

  • Linda Mahjoubi

  • Antoine Hollebecque

  • Jean-Yves Scoazec

  • Aurelien Marabelle

  • Christophe Massard

  • Jean-Charles Soria

  • Charlotte Robert

  • Nikos Paragios

  • Eric Deutsch

  • Charles Ferte

Medical Centers

  • Gustave Roussy Cancer Campus, Radiation oncology department,, Villejuif, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Center for Visual Computing - CentraleSupelec - INRIA - University Paris-Saclay, Gif-Sur-Yvette, France

  • Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY

  • Drug Development Department (DITEP), Gustave Roussy, Villejuif, France

  • Hopital Nord Franche - Comte, Pathology department, Trevenans, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Clarac Hospital, Fort De France, Martinique

  • Gustave Roussy, Villejuif, France

  • Department of Biopathology. Gustave Roussy Cancer Campus, Villejuif, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Institut Gustave-Roussy, Villejuif, France

  • Institut Gustave Roussy, St Maur Des Fosses, France

Locations

  • France

  • Martinique

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved